Home Page
Health Care Providers Section

E-mail this page   Printable View

Polycystic Ovarian Syndrome: References

1. Bilo L, Meo R, Valentino R, Di Carlo C, Striano S, Nappi C. Characterization of reproductive endocrine disorders in women with epilepsy. J Clin Endocrinol Metab. 2001;86:2950–2956.

2. Azziz R, Kashar–Miller MD. Family history as a risk factor for the polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2000;13(suppl 5):1303–1306.

3. The Rotterdam ESHRE/ASRM–Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long–term health risks related to polycystic ovary syndrome. Hum Reprod. 2004;19:41–47.

4. Marsh K, Brand–Miller J. The optimal diet for women with polycystic ovary syndrome? Br J Nutr. 2005;94:154–165.

5. Stamets K, Taylor DS, Kunselman A, Demers LM, Pelkman CL, Legro RS. A randomized trial of the effects of two types of short–term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril. 2004;81:630–637.

6. Hahn S, Tan S, Elsenbruch S, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine–Westphalia. Horm Metab Res. 2005;37:438–444.

7. Holte J. Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over–feeding and sedentary life style? J Endocrinol Invest. 1998;21:589–601.

8. Berrino F, Bellati C, Secreto G, et al. Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev. 2001;10:25–33.

9. Nestler JE, Jakubowicz DJ, Reamer P, Gunn RD, Allan G. Ovulatory and metabolic effects of D–chiro–inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340:1314–1320.

10. Iuorno MJ, Jakubowicz DJ, Baillargeon JP, et al. Effects of d–chiro–inositol in lean women with the polycystic ovary syndrome. Endocr Pract. 2002;8:417–423.

11. Gerli S, Mignosa M, Di Renzo GC. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo–controlled trial. Eur Rev Med Pharmacol Sci. 2003;7:151–159.

12. Baillargeon JP, Jakubowicz DJ, Iuorno MJ, Jakubowicz S, Nestler JE. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril. 2004;82:893–902.

Previous:
<< Polycystic Ovarian Syndrome: Nutritional Considerations